Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 3Terminated 2Completed 2Withdrawn 1Active not recruiting 1

Sponsor Class

NETWORK 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Colorectal Neoplasms 136Head and Neck Neoplasms 95Squamous Cell Carcinoma of Head and Neck 89Carcinoma, Non-Small-Cell Lung 58Colonic Neoplasms 44Rectal Neoplasms 38Neoplasm Metastasis 33Neoplasms 28Pancreatic Neoplasms 24Lung Neoplasms 18Carcinoma, Squamous Cell 18Stomach Neoplasms 15Tongue Neoplasms 13Esophageal Neoplasms 13Salivary Gland Neoplasms 11Recurrence 10Breast Neoplasms 10Laryngeal Neoplasms 9Mouth Neoplasms 8Esophageal Squamous Cell Carcinoma 8Carcinoma 8Adenocarcinoma Of Esophagus 8Adenocarcinoma of Lung 7Neoplasms, Squamous Cell 6Hypopharyngeal Neoplasms 6Carcinoma, Renal Cell 6Parkinson Disease 4, Autosomal Dominant Lewy Body 5Oropharyngeal Neoplasms 5Nasopharyngeal Carcinoma 5Carcinoma, Hepatocellular 5

Interventions

Carboplatin 177Paclitaxel 176Bevacizumab 72Topotecan 55liposomal doxorubicin 54Gemcitabine 53Cisplatin 46Docetaxel 39Cyclophosphamide 37olaparib 32Filgrastim 31pembrolizumab 29Doxorubicin 26niraparib 24Taxes 23Drug Therapy 23Peripheral Blood Stem Cell Transplantation 20Etoposide 17veliparib 15Nivolumab 14sargramostim 13Surveys and Questionnaires 13Immunoglobulin G 13Disulfides 13pazopanib 12Ifosfamide 12Albumin-Bound Paclitaxel 12durvalumab 11atezolizumab 11Trabectedin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Ovarian Neoplasms × Cetuximab × Clear all
NCT00086892 2014-02-14

Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer

GOG Foundation

Phase 2 Completed
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00063401 2010-04-08

Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer

Eli Lilly and Company

Phase 2 Completed
39 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡